Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Messoud Ashina

Showing results (371-380 of 432) with videos related to

Pageof 44
Sort By:
Cephalalgia : an International Journal of Headache|August 20, 2025
Long-term safety, efficacy and functional outcomes of atogepant for the preventive treatment of migraineSait Ashina, Messoud Ashina, Dagny Holle-Lee, et al.
Pain|May 28, 2014
Association of acetazolamide infusion with headache and cranial artery dilation in healthy volunteersNanna Arngrim, Henrik Winther Schytz, Mohammad Sohail Asghar, et al.
Neurology|April 19, 2019
Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trialStewart J Tepper, Hans-Christoph Diener, Messoud Ashina, et al.
The Lancet. Neurology|September 17, 2023
Migraine in older adultsSarah Sonja Hugger, Thien Phu Do, Håkan Ashina, et al.
The Journal of Headache and Pain|March 11, 2024
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trialsPaul Rizzoli, Michael J Marmura, Jennifer Robblee, et al.
Pain|May 5, 2025
Induction of cluster headache after opening of adenosine triphosphate-sensitive potassium channels: a randomized clinical trialHaidar M Al-Khazali, Christina I Deligianni, Lanfranco Pellesi, et al.
Lancet (London, England)|August 21, 2019
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trialMichel D Ferrari, Hans Christoph Diener, Xiaoping Ning, et al.
Brain : a Journal of Neurology|April 16, 2026
Calcitonin gene-related peptide induces headache attacks in people with idiopathic intracranial hypertensionAndreas Yiangou, Thien Phu Do, Susan P Mollan, et al.
Cephalalgia : an International Journal of Headache|September 2, 2025
Migraine stigma and general knowledge of migraine: A cross-sectional European surveyPeter J Goadsby, Elena Ruiz de la Torre, Antoinette Maassen van den Brink, et al.
Pain|December 21, 2023
Induction of cluster headache after opening of adenosine triphosphate-sensitive potassium channels: a randomized clinical trialHaidar M Al-Khazali, Christina I Deligianni, Lanfranco Pellesi, et al.
Pageof 44

Showing results (371-380 of 432) with videos related to

Sort By:
Pageof 44
Cephalalgia : an International Journal of Headache|August 20, 2025
Long-term safety, efficacy and functional outcomes of atogepant for the preventive treatment of migraineSait Ashina, Messoud Ashina, Dagny Holle-Lee, et al.
Pain|May 28, 2014
Association of acetazolamide infusion with headache and cranial artery dilation in healthy volunteersNanna Arngrim, Henrik Winther Schytz, Mohammad Sohail Asghar, et al.
Neurology|April 19, 2019
Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trialStewart J Tepper, Hans-Christoph Diener, Messoud Ashina, et al.
The Lancet. Neurology|September 17, 2023
Migraine in older adultsSarah Sonja Hugger, Thien Phu Do, Håkan Ashina, et al.
The Journal of Headache and Pain|March 11, 2024
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trialsPaul Rizzoli, Michael J Marmura, Jennifer Robblee, et al.
Pain|May 5, 2025
Induction of cluster headache after opening of adenosine triphosphate-sensitive potassium channels: a randomized clinical trialHaidar M Al-Khazali, Christina I Deligianni, Lanfranco Pellesi, et al.
Lancet (London, England)|August 21, 2019
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trialMichel D Ferrari, Hans Christoph Diener, Xiaoping Ning, et al.
Brain : a Journal of Neurology|April 16, 2026
Calcitonin gene-related peptide induces headache attacks in people with idiopathic intracranial hypertensionAndreas Yiangou, Thien Phu Do, Susan P Mollan, et al.
Cephalalgia : an International Journal of Headache|September 2, 2025
Migraine stigma and general knowledge of migraine: A cross-sectional European surveyPeter J Goadsby, Elena Ruiz de la Torre, Antoinette Maassen van den Brink, et al.
Pain|December 21, 2023
Induction of cluster headache after opening of adenosine triphosphate-sensitive potassium channels: a randomized clinical trialHaidar M Al-Khazali, Christina I Deligianni, Lanfranco Pellesi, et al.
Pageof 44